Genrix Bio
688443 · SSE STAR Market
Public Market Listing
Live quotes, historical charts, and market capitalization for Genrix Bio are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(3 total)
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | IL-4R-alphaMonoclonal antibody | Atopic Dermatitis | |
| Phase 3 | BCMA x CD3Multispecific antibody | Multiple Myeloma | |
| Phase 1 | TSLPMultispecific antibody | Atopic Dermatitis |
Upcoming events
(6 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2027 (4)
May 2027 (2)
June 2027 (1)
What to watch
July 2027 (1)
What to watch
2029 (2)
January 2029 (1)
What to watch
March 2029 (1)
What to watch
Regulatory and conference events
(4)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
Financial reports
Annual history (1 year)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-FY | $32M | $66M | — | $19M | report ↗ |